The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives
International Journal of Molecular Sciences · 03.09.2024 · 25 (17) · 9555
DOI: 10.3390/ijms25179555 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.09.2024. Verfasst von Fotini Poyia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Tumor Microenvironment, Metastasis and Experimental Therapeutics Laboratory, Basic and Translational Cancer Research Center, Department of Life Scien…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Immunotherapy, Pancreatic Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research and Innovation Foundation, European Regional Development Fund and the Republic of Cyprus through the Research and Innovation Foundation.
Abstract (Originalsprache)
Pancreatic cancer comprises different subtypes, where most cases include ductal adenocarcinoma (PDAC). It is one of the deadliest tumor types, with a poor prognosis. In the majority of patients, the disease has already spread by the time of diagnosis, making full recovery unlikely and increasing mortality risk. Despite developments in its detection and management, including chemotherapy, radiotherapy, and targeted therapies as well as advances in immunotherapy, only in about 13% of PDAC patients does the overall survival exceed 5 years. This may be attributed, at least in part, to the highly desmoplastic tumor microenvironment (TME) that acts as a barrier limiting perfusion, drug delivery, and immune cell infiltration and contributes to the establishment of immunologically ‘cold’ conditions. Therefore, there is an urgent need to unravel the complexity of the TME that promotes PDAC progression and decipher the mechanisms of pancreatic tumors’ resistance to immunotherapy. In this review, we provide an overview of the major cellular and non-cellular components of PDAC TME, as well as their biological interplays. We also discuss the current state of PDAC therapeutic treatments and focus on ongoing and future immunotherapy efforts and multimodal treatments aiming at remodeling the TME to improve therapeutic efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tumor Microenvironment, Metastasis and Experimental Therapeutics Laboratory, Basic and Translational Cancer Research Center, Department of Life Sciences, European University Cyprus, Nicosia 2404, Cyprus.
- Apoptosis and Cancer Chemoresistance Laboratory, Basic and Translational Cancer Research Center, Department of Life Sciences, European University Cyprus, Nicosia 2404, Cyprus.
- Tumor Immunology and Biomarkers Laboratory, Basic and Translational Cancer Research Center, Department of Life Sciences, European University Cyprus, Nicosia 2404, Cyprus.
ORCID-Profile: Christiana M Neophytou, Maria-Ioanna Christodoulou, Panagiotis Papageorgis
Förderung
- Research and Innovation Foundation
- European Regional Development Fund and the Republic of Cyprus through the Research and Innovation Foundation
Zitieren
APA
Poyia, F., Neophytou, C. M., Christodoulou, M. I., & Papageorgis, P. (2024). The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives. International Journal of Molecular Sciences, 25(17), 9555. https://doi.org/10.3390/ijms25179555
Vancouver
Poyia F, Neophytou CM, Christodoulou MI, Papageorgis P. The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives. International Journal of Molecular Sciences. 2024;25(17):9555. doi:10.3390/ijms25179555
BibTeX
@article{Poyia2024,
author = {Poyia, Fotini and Neophytou, Christiana M and Christodoulou, Maria-Ioanna and Papageorgis, Panagiotis},
title = {The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {17},
pages = {9555},
doi = {10.3390/ijms25179555}
}
EUVIMED